60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases
October 12, 2023 16:16 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma Suspends Phase IIB COVID Study, Pivots to Commercialization of Treatments for Malaria
and Tick-borne Illness
Surprising Study: Brain Exercise Helps with Knee Surgery Recovery
July 17, 2023 07:55 ET
|
Posit Science
SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- A new study, published in the journal Healthcare, somewhat surprisingly found that a small amount of brain training helped with recovery from knee...